Macouzet S, Ocampo CL, Sumano LH

Language: English/Spanish
References: 16
Page: 286-291
PDF size: 81.17 Kb.

ABSTRACT

Pharmacokinetic variables of a new antibacterial agent called cefalone (CQMPCA), worldwide patented, were established in Holstein cows in Mexico. Twenty four Holstein cows were divided into four groups of six animals each as follows: Group 1, receiving 10 mg/kg of CQMPCA in a single IV bolus injection; Group 2 the same dose but injected IM; Group 3 receiving 5 mg/kg of CQMPCA in a single IV bolus injection, and Group 4 as for Group 2 but at 5 mg/kg. Blood samples from all animals were obtained with a catheter implanted in the jugular vein, at different times for 8 hours. Analytical techniques to quantify CQMPCA included UV-visible spectrophotometry and high pressure liquid chromatography (HPLC). Plasma concentration vs. time relationship in all four groups were best described by a two compartment open model. Correlation between b angles in all four groups suggested that using the dose ranges specified above, the drug would follow a first order kinetics. An 84% bioavailability was calculated after the IM injection of the drug, and a maximal plasma concentration after the IM injection of i.57 µmg/ml after 2.6 h from the injection. Apparent volume of distribution (Vdarea) was set at 2.86L/kg and a half life of the post-distribution phase of 3.58 h. Based on these results, it is concluded that CQMPCA possesses suituable characteristic similar to third generation cephalosporins which included high tissue distribution and relatively slow body clearance. These pharmacokinetic features and previous references of potent in vitro antibacterial activity suggest excellent clinical efficacy. It is suggested that more studies should be followed.

REFERENCES

1. Sumano H. Quinolonas y fluroquinolonas en medicina veterinaria. Vet Méx 1993;24:83-92.

2. Ito A, Hirai K, Inove M, Koga H, Suzue S, Irikure T, Misahushi S. The in vitro antibacterial activity of AM-715 a new nalidixic acid analogue. Antimicrob Agents Chemother 1980;17:103-108.

3. Bergan T. Quinolones. In: Antimicrobial annual 2. Amsterdam, The Netherlands: Elsevier, 1987.

4. Chu DTW, Fernández PB. Structure activity relationship of the fluoroquinolones. Antimicrob Agents Chemother 1989;33:131-135.

5. Santamaría JA. Eficacia clínica de un preparado intramamario a base de una cefaquinolona experimental (CQEPA-600M), para el tratamiento de la mastitis bovina (tesis de licenciatura). México (DF): Facultad de Medicina Veterinaria y Zootecnia. UNAM, 1997.

6. Johnson D, Erwin M, Jones RN. Antimicrobial activity and spectrum of novel cephalosporin-fluoroquinolone dual action compounds (DAC), CQEPCTM-397 and CQEPTM (414). Proceedings of the 36th Interscience Conference on Antimicrobial Agents and Chemotheraphy; 1996 September 15-18; New Orleans (New Orleans): American Society for Microbiology, 1996:128.

7. Adams R. Veterinary pharmacology and therapeutics. Ames (Io): Iowa State University Press, 1997.

8. Sumano H, Ocampo L. Bases farmacológicas de la vigilancia de residuos en productos de origen animal. Vet Méx 1995;26:75-78.

9. García ME. Modificaciones al sistema de clasificación climática de Köppen (para adaptarlo a las condiciones de la república mexicana. 3a ed. México (DF): Instituto de Geografía, Universidad Nacional Autónoma de México, 1981.

10. Rule R, Quiroga GH, Rubio M, Buschiazzo HO, Buschiazzo PM. The pharmacokinetics of ceftazidime in lactating and non lactating cows. Vet Res Commun 1996;20:543-550.

11. Rowland M, Tozer TN. Variability. In: Williams & Wilkins. Clinical pharmacokinetics: concepts and applications. 2nd ed. Philadelphia: Lea & Febiger, 1989:197-211.

12. Craigmill AL, Sundlof SF, Riviere JE. Handbook of comparative pharmacokinetics and residues of veterinary therapeutic drugs. Boca Raton (Fl): CRC Press, 1994.

13. Brow SA, Chester ST, Robb EJ. Effect of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle. J Vet Pharmacol Ther 1996;19:32-38.

14. Courtin F, Craigmill SE, Wetzlich SE, Gustafson RC, Arndt TS. Phamacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to dairy goats. J Vet Pharmacol Ther 1996;19:32-38.

15. Thomson TD, Quay JF, Webber JA. Cephalosporin group of antimicrobial drugs. J Am Vet Med Assoc 1984;10:15.

16. Méndez LA. Evaluación de la potencia y determinación del espectro antibacteriano de una cefaloquinolona de desarrollo nacional (tesis de licenciatura). México (DF): Facultad de Medicina Veterinaria y Zootecnia. UNAM, 1996.